Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Gibson Christopher
Director at RECURSION PHARMACEUTICALS. Filing since 7 Dec 2021.
CIK 0001856369
Company
Date
Role
Action
Shares
Amount
Of holding
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Jun 2026
Director
Sold on a plan
40,000
$144.80K
4.3%
RXRX
RECURSION PHARMACEUTICALS, INC.
22 May 2026
Director
Sold on a plan
40,000
$123.20K
4.3%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 May 2026
Director
Sold on a plan
40,000
$134.80K
4.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
22 Apr 2026
Director
Sold on a plan
40,000
$144.40K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Apr 2026
Director
Sold on a plan
40,000
$124.00K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
23 Mar 2026
Director
Sold on a plan
40,000
$130.00K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
19 Feb 2026
Director
Sold on a plan
40,000
$138.40K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Feb 2026
Director
Sold on a plan
40,000
$164.80K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
20 Jan 2026
Director
Sold on a plan
40,000
$178.80K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Jan 2026
Director
Sold on a plan
40,000
$170.00K
4.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
19 Dec 2025
Chief Executive Officer
Sold on a plan
40,000
$180.00K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Dec 2025
Chief Executive Officer
Sold on a plan
40,000
$185.20K
4.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
19 Nov 2025
Chief Executive Officer
Sold on a plan
40,000
$166.40K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Nov 2025
Chief Executive Officer
Sold on a plan
40,000
$208.40K
3.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
23 Oct 2025
Chief Executive Officer
Sold on a plan
100,000
$570.00K
9.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
10 Oct 2025
Chief Executive Officer
Sold on a plan
100,000
$604.00K
9.3%
RXRX
RECURSION PHARMACEUTICALS, INC.
25 Sep 2025
Chief Executive Officer
Sold on a plan
100,000
$476.00K
9.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
10 Sep 2025
Chief Executive Officer
Sold on a plan
100,000
$471.00K
9.3%
RXRX
RECURSION PHARMACEUTICALS, INC.
26 Aug 2025
Chief Executive Officer
Sold on a plan
100,000
$484.00K
9.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
11 Aug 2025
Chief Executive Officer
Sold on a plan
500,300
$2.64M
33.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
11 Aug 2025
Chief Executive Officer
Sold on a plan
117,875
$622.38K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
27 Mar 2025
Chief Executive Officer
Sold on a plan
138,574
$836.99K
11.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Mar 2025
Chief Executive Officer
Sold on a plan
20,000
$127.40K
1.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Mar 2025
Chief Executive Officer
Sold on a plan
20,000
$131.60K
1.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Feb 2025
Chief Executive Officer
Sold on a plan
20,000
$162.40K
1.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Feb 2025
Chief Executive Officer
Sold on a plan
20,000
$153.60K
1.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
10 Jan 2025
Chief Executive Officer
Sold on a plan
20,000
$141.00K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Jan 2025
Chief Executive Officer
Sold on a plan
20,000
$146.20K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Dec 2024
Chief Executive Officer
Sold on a plan
20,000
$142.40K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Dec 2024
Chief Executive Officer
Sold on a plan
20,000
$143.20K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Nov 2024
Chief Executive Officer
Sold on a plan
20,000
$147.00K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Nov 2024
Chief Executive Officer
Sold on a plan
20,000
$154.80K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 Oct 2024
Chief Executive Officer
Sold on a plan
20,000
$121.60K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Oct 2024
Chief Executive Officer
Sold on a plan
20,000
$123.20K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Sep 2024
Chief Executive Officer
Sold on a plan
20,000
$122.80K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Sep 2024
Chief Executive Officer
Sold on a plan
20,000
$120.80K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Aug 2024
Chief Executive Officer
Sold on a plan
20,000
$130.00K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Aug 2024
Chief Executive Officer
Sold on a plan
30,000
$213.00K
3.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
11 Jul 2024
Chief Executive Officer
Sold on a plan
50,000
$373.50K
6.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
10 Jul 2024
Chief Executive Officer
Sold on a plan
50,000
$374.00K
6.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Jun 2024
Chief Executive Officer
Sold on a plan
50,000
$450.00K
6.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Jun 2024
Chief Executive Officer
Sold on a plan
50,000
$421.00K
6.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 May 2024
Chief Executive Officer
Sold on a plan
50,000
$423.50K
5.7%
RXRX
RECURSION PHARMACEUTICALS, INC.
1 May 2024
Chief Executive Officer
Sold on a plan
50,000
$386.50K
5.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Apr 2024
Chief Executive Officer
Sold on a plan
40,000
$360.80K
4.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Apr 2024
Chief Executive Officer
Sold on a plan
25,000
$225.50K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 Apr 2024
Chief Executive Officer
Sold on a plan
40,000
$353.60K
3.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 Apr 2024
Chief Executive Officer
Sold on a plan
25,000
$221.00K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
28 Mar 2024
Chief Executive Officer
Sold on a plan
40,000
$404.00K
3.7%
RXRX
RECURSION PHARMACEUTICALS, INC.
28 Mar 2024
Chief Executive Officer
Sold on a plan
25,000
$252.50K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Mar 2024
Chief Executive Officer
Sold at will
36,319
$430.68K
3.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Mar 2024
Chief Executive Officer
Sold at will
25,000
$288.82K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Feb 2024
Chief Executive Officer
Sold at will
48,272
$444.98K
5.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 Jan 2024
Chief Executive Officer
Sold at will
30,853
$292.80K
3.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 Jan 2024
Chief Executive Officer
Sold at will
25,000
$237.76K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Dec 2023
Chief Executive Officer
Sold at will
59,829
$448.39K
7.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
1 Nov 2023
Chief Executive Officer
Sold at will
37,177
$193.31K
4.3%
RXRX
RECURSION PHARMACEUTICALS, INC.
1 Nov 2023
Chief Executive Officer
Sold at will
25,000
$128.00K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Oct 2023
Chief Executive Officer
Sold at will
59,794
$431.03K
6.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Sep 2023
Chief Executive Officer
Sold at will
33,765
$296.57K
3.7%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Sep 2023
Chief Executive Officer
Sold at will
25,000
$220.87K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Aug 2023
Chief Executive Officer
Sold at will
65,015
$847.71K
6.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
12 Jul 2023
Chief Executive Officer
Sold at will
31,818
$417.98K
3.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
12 Jul 2023
Chief Executive Officer
Sold at will
25,000
$294.27K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Jun 2023
Chief Executive Officer
Sold at will
56,436
$510.81K
5.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 May 2023
Chief Executive Officer
Sold at will
33,073
$155.76K
3.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 May 2023
Chief Executive Officer
Sold at will
25,000
$122.57K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Apr 2023
Chief Executive Officer
Sold at will
40,000
$265.67K
4.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Apr 2023
Chief Executive Officer
Sold at will
13,327
$86.04K
1.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
9 Mar 2023
Chief Executive Officer
Sold, plan not stated
15,000
$116.62K
1.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Mar 2023
Chief Executive Officer
Sold, plan not stated
70,890
$573.93K
6.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Mar 2023
Chief Executive Officer
Sold, plan not stated
25,000
$202.35K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Mar 2023
Chief Executive Officer
Sold, plan not stated
18,500
$146.50K
1.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Mar 2023
Chief Executive Officer
Sold, plan not stated
2,500
$19.77K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Feb 2023
Chief Executive Officer
Sold, plan not stated
18,500
$170.55K
1.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Feb 2023
Chief Executive Officer
Sold, plan not stated
2,500
$23.01K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Jan 2023
Chief Executive Officer
Sold, plan not stated
18,500
$136.67K
3.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Jan 2023
Chief Executive Officer
Sold, plan not stated
2,500
$18.46K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
1 Dec 2022
Chief Executive Officer
Sold, plan not stated
37,210
$335.76K
6.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
1 Dec 2022
Chief Executive Officer
Sold, plan not stated
2,500
$23.19K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 Nov 2022
Chief Executive Officer
Sold, plan not stated
36,693
$366.95K
6.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
3 Nov 2022
Chief Executive Officer
Sold, plan not stated
2,500
$25.25K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Oct 2022
Chief Executive Officer
Sold, plan not stated
36,053
$417.47K
6.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Oct 2022
Chief Executive Officer
Sold, plan not stated
2,500
$29.11K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
1 Sep 2022
Chief Executive Officer
Sold, plan not stated
36,566
$377.94K
6.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
1 Sep 2022
Chief Executive Officer
Sold, plan not stated
2,500
$26.26K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Aug 2022
Chief Executive Officer
Sold, plan not stated
36,825
$349.44K
6.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 Aug 2022
Chief Executive Officer
Sold, plan not stated
2,500
$23.62K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Jul 2022
Chief Executive Officer
Sold, plan not stated
37,114
$335.98K
6.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Jul 2022
Chief Executive Officer
Sold, plan not stated
2,500
$22.67K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Jun 2022
Chief Executive Officer
Sold, plan not stated
39,690
$241.77K
7.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
2 Jun 2022
Chief Executive Officer
Sold, plan not stated
2,500
$15.86K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 May 2022
Chief Executive Officer
Sold, plan not stated
18,500
$119.12K
3.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 May 2022
Chief Executive Officer
Sold, plan not stated
2,500
$16.09K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 May 2022
Chief Executive Officer
Sold, plan not stated
31,830
$206.50K
5.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
4 May 2022
Chief Executive Officer
Sold, plan not stated
2,500
$16.19K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
29 Apr 2022
Chief Executive Officer
Sold, plan not stated
38,070
$235.33K
7.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
29 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$15.77K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
28 Apr 2022
Chief Executive Officer
Sold, plan not stated
37,605
$229.12K
7.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
28 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$15.17K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
22 Apr 2022
Chief Executive Officer
Sold, plan not stated
37,953
$229.17K
7.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
22 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$15.01K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
21 Apr 2022
Chief Executive Officer
Sold, plan not stated
37,155
$234.63K
8.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
21 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$15.47K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
18 Apr 2022
Chief Executive Officer
Sold, plan not stated
35,836
$245.07K
8.3%
RXRX
RECURSION PHARMACEUTICALS, INC.
18 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$16.77K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Apr 2022
Chief Executive Officer
Sold, plan not stated
34,517
$260.86K
8.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$18.77K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Apr 2022
Chief Executive Officer
Sold, plan not stated
36,920
$243.22K
9.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$16.77K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Apr 2022
Chief Executive Officer
Sold, plan not stated
36,718
$240.24K
10.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$16.28K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Apr 2022
Chief Executive Officer
Sold, plan not stated
35,826
$242.71K
11.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
6 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$16.41K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Apr 2022
Chief Executive Officer
Sold, plan not stated
34,472
$256.23K
11.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Apr 2022
Chief Executive Officer
Sold, plan not stated
2,500
$18.28K
100%
RXRX
RECURSION PHARMACEUTICALS, INC.
15 Mar 2022
Chief Executive Officer
Sold, plan not stated
6,150
$37.41K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Mar 2022
Chief Executive Officer
Sold, plan not stated
230,000
$1.44M
49.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
11 Mar 2022
Chief Executive Officer
Sold, plan not stated
100,000
$694.58K
29.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Mar 2022
Chief Executive Officer
Sold, plan not stated
300,000
$2.19M
56.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
22 Feb 2022
Chief Executive Officer
Sold, plan not stated
100,000
$1.02M
29.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
31 Jan 2022
Chief Executive Officer
Sold, plan not stated
19,858
$232.96K
45.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Jan 2022
Chief Executive Officer
Sold, plan not stated
254,000
$3.45M
91.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Jan 2022
Chief Executive Officer
Sold, plan not stated
87,000
$1.25M
78.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
16 Dec 2021
Chief Executive Officer
Sold, plan not stated
200
$4.00K
0.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Dec 2021
Chief Executive Officer
Sold, plan not stated
100
$2.00K
0.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
9 Dec 2021
Chief Executive Officer
Sold, plan not stated
1,086
$21.73K
4.4%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Dec 2021
Chief Executive Officer
Sold, plan not stated
10,664
$214.83K
31.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Dec 2021
Chief Executive Officer
Sold, plan not stated
16,667
$341.33K
0.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
7 Dec 2021
Chief Executive Officer
Sold, plan not stated
3,125
$64.10K
2.1%
130 decisions on file.
